Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1993 Jun 26;306(6894):1722–1725. doi: 10.1136/bmj.306.6894.1722

Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes?

K Borch-Johnsen 1, H Wenzel 1, G C Viberti 1, C E Mogensen 1
PMCID: PMC1678304  PMID: 8343628

Abstract

OBJECTIVE--To analyse the cost-benefit of screening for and antihypertensive treatment of early renal disease indicated by microalbuminuria in patients with insulin dependent diabetes mellitus. DESIGN--Previously published data were used to estimate transition probabilities for each step from normoalbuminuria until death. The effect of intervention on urinary albumin excretion rate by antihypertensive treatment was arbitrarily set at three different levels. All direct costs (screening, antihypertensive treatment, treatment of end stage renal failure) were included in the cost-benefit analysis by using real discount rates of 2.5% and 6%. SETTING--Computer simulation. SUBJECTS--Simulated cohort of 8000 patients. MAIN OUTCOME MEASURES--Mortality, incidence of diabetic nephropathy, incidence of end stage renal failure, and costs versus savings. RESULTS--Assuming treatment effects of 33% and 67% median life expectancy increased by four to 14 years, respectively, and the need for dialysis or transplantation decreased by 21% to 63%. Costs and savings would balance if the annual rate of increase of albuminuria was decreased from 20% to 18% a year. CONCLUSIONS--Screening and intervention programmes are likely to have life saving effects and lead to considerable economic savings.

Full text

PDF
1722

Images in this article

1724p1724-a
on p.1724

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borch-Johnsen K., Andersen P. K., Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1985 Aug;28(8):590–596. doi: 10.1007/BF00281993. [DOI] [PubMed] [Google Scholar]
  2. Borch-Johnsen K., Kreiner S. Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) 1987 Jun 27;294(6588):1651–1654. doi: 10.1136/bmj.294.6588.1651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Borch-Johnsen K. The prognosis of insulin-dependent diabetes mellitus. An epidemiological approach. Dan Med Bull. 1989 Sep;36(4):336–348. [PubMed] [Google Scholar]
  4. Christensen C. K., Mogensen C. E. Antihypertensive treatment: long-term reversal of progression of albuminuria in incipient diabetic nephropathy. A longitudinal study of renal function. J Diabet Complications. 1987 Apr-Jun;1(2):45–52. doi: 10.1016/s0891-6632(87)80079-x. [DOI] [PubMed] [Google Scholar]
  5. Christensen C. K. The pre-proteinuric phase of diabetic nephropathy. Dan Med Bull. 1991 Apr;38(2):145–159. [PubMed] [Google Scholar]
  6. Damsgaard E. M., Frøland A., Jørgensen O. D., Mogensen C. E. Eight to nine year mortality in known non-insulin dependent diabetics and controls. Kidney Int. 1992 Apr;41(4):731–735. doi: 10.1038/ki.1992.114. [DOI] [PubMed] [Google Scholar]
  7. Damsgaard E. M., Frøland A., Jørgensen O. D., Mogensen C. E. Microalbuminuria as predictor of increased mortality in elderly people. BMJ. 1990 Feb 3;300(6720):297–300. doi: 10.1136/bmj.300.6720.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Doubilet P., Begg C. B., Weinstein M. C., Braun P., McNeil B. J. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making. 1985 Summer;5(2):157–177. doi: 10.1177/0272989X8500500205. [DOI] [PubMed] [Google Scholar]
  9. Hallab M., Gallois Y., Chatellier G., Rohmer V., Fressinaud P., Marre M. Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes. BMJ. 1993 Jan 16;306(6871):175–182. doi: 10.1136/bmj.306.6871.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jensen T., Borch-Johnsen K., Kofoed-Enevoldsen A., Deckert T. Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia. 1987 Mar;30(3):144–148. doi: 10.1007/BF00274218. [DOI] [PubMed] [Google Scholar]
  11. Kofoed-Enevoldsen A., Borch-Johnsen K., Kreiner S., Nerup J., Deckert T. Declining incidence of persistent proteinuria in type I (insulin-dependent) diabetic patients in Denmark. Diabetes. 1987 Feb;36(2):205–209. doi: 10.2337/diab.36.2.205. [DOI] [PubMed] [Google Scholar]
  12. Kofoed-Enevoldsen A., Jensen T., Borch-Johnsen K., Deckert T. Incidence of retinopathy in type I (insulin-dependent) diabetes: association with clinical nephropathy. J Diabet Complications. 1987 Jul-Sep;1(3):96–99. doi: 10.1016/s0891-6632(87)80064-8. [DOI] [PubMed] [Google Scholar]
  13. Krolewski A. S., Warram J. H., Christlieb A. R., Busick E. J., Kahn C. R. The changing natural history of nephropathy in type I diabetes. Am J Med. 1985 May;78(5):785–794. doi: 10.1016/0002-9343(85)90284-0. [DOI] [PubMed] [Google Scholar]
  14. Krolewski A. S., Warram J. H., Rand L. I., Christlieb A. R., Busick E. J., Kahn C. R. Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: a 40-yr follow-up study. Diabetes Care. 1986 Sep-Oct;9(5):443–452. doi: 10.2337/diacare.9.5.443. [DOI] [PubMed] [Google Scholar]
  15. Marre M., Chatellier G., Leblanc H., Guyene T. T., Menard J., Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ. 1988 Oct 29;297(6656):1092–1095. doi: 10.1136/bmj.297.6656.1092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Marshall S. M., Alberti K. G. Comparison of the prevalence and associated features of abnormal albumin excretion in insulin-dependent and non-insulin-dependent diabetes. Q J Med. 1989 Jan;70(261):61–71. [PubMed] [Google Scholar]
  17. Mathiesen E. R., Borch-Johnsen K., Jensen D. V., Deckert T. Improved survival in patients with diabetic nephropathy. Diabetologia. 1989 Dec;32(12):884–886. doi: 10.1007/BF00297455. [DOI] [PubMed] [Google Scholar]
  18. Mathiesen E. R., Hommel E., Giese J., Parving H. H. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ. 1991 Jul 13;303(6794):81–87. doi: 10.1136/bmj.303.6794.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mathiesen E. R., Oxenbøll B., Johansen K., Svendsen P. A., Deckert T. Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia. 1984 Jun;26(6):406–410. doi: 10.1007/BF00262210. [DOI] [PubMed] [Google Scholar]
  20. Mogensen C. E., Chachati A., Christensen C. K., Close C. F., Deckert T., Hommel E., Kastrup J., Lefebvre P., Mathiesen E. R., Feldt-Rasmussen B. Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest. 1985;9(2):85–95. doi: 10.3109/08860228509088195. [DOI] [PubMed] [Google Scholar]
  21. Mogensen C. E., Christensen C. K. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med. 1984 Jul 12;311(2):89–93. doi: 10.1056/NEJM198407123110204. [DOI] [PubMed] [Google Scholar]
  22. Mogensen C. E. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J (Clin Res Ed) 1982 Sep 11;285(6343):685–688. doi: 10.1136/bmj.285.6343.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Parving H. H., Oxenbøll B., Svendsen P. A., Christiansen J. S., Andersen A. R. Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 1982 Aug;100(4):550–555. doi: 10.1530/acta.0.1000550. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES